Hidradenitis suppurativa, which treatment is better: doxycycline or a combination of clindamycin and rifampicin?

被引：0
|
作者：
Kappe, N. [1 ]
van Straalen, K. [1 ]
van der Zee, H. [1 ]
机构：
[1] Erasmus MC, Dept Dermatol, Rotterdam, Netherlands
来源：
EXPERIMENTAL DERMATOLOGY | 2018年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P046
引用
收藏
页码：31 / 31
页数：1
相关论文
共 50 条
  • [41] Treatment of hidradenitis suppurativa with rifampicin: have we forgotten tuberculosis?
    Mendes-Bastos, P.
    Macedo, R.
    Duarte, R.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (04) : E150 - E151
  • [42] Dramatic reduction of clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampin-clindamycin combination
    Join-Lambert, Olivier
    Ribadeau-Dumas, Florence
    Jullien, Vincent
    Kitzis, Marie-Dominique
    Jais, Jean-Philippe
    Coignard-Biehler, Helene
    Guet-Revillet, Helene
    Consigny, Paul-Henri
    Delage, Maia
    Nassif, Xavier
    Lortholary, Olivier
    Nassif, Aude
    EUROPEAN JOURNAL OF DERMATOLOGY, 2014, 24 (01) : 94 - 95
  • [43] Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa
    Rosi, Elia
    Pescitelli, Leonardo
    Ricceri, Federica
    Di Cesare, Antonella
    Novelli, Andrea
    Pimpinelli, Nicola
    Prignano, Francesca
    DERMATOLOGIC THERAPY, 2019, 32 (02)
  • [44] Bacteriology of Hidradenitis Suppurativa - Which Antibiotics are the Treatment of Choice?
    Matusiak, Lukasz
    Bieniek, Andrzej
    Szepietowski, Jacek C.
    ACTA DERMATO-VENEREOLOGICA, 2014, 94 (06) : 699 - 702
  • [45] Dramatic reduction of clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampinclindamycin combination
    Olivier Join-Lambert
    Florence Ribadeau-Dumas
    Vincent Jullien
    Marie-Dominique Kitzis
    Jean-Philippe Jais
    Hélène Coignard-Biehler
    Hélène Guet-Revillet
    Paul-Henri Consigny
    Maia Delage
    Xavier Nassif
    Olivier Lortholary
    Aude Nassif
    European Journal of Dermatology, 2014, 24 : 94 - 95
  • [46] Moxifloxacin-metronidazole combination without rifampicin for the treatment of hidradenitis suppurativa: experience in a tuberculosis-endemic country
    Reyes-Baraona, Francisco
    Garcia-Huidobro, Isidora
    Josefina Lorenzoni, Maria
    EXPERIMENTAL DERMATOLOGY, 2022, 31 : 102 - 103
  • [47] Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: an observational study to assess prevalence and causes
    Pascual, J. C.
    Schneller-Pavelescu, L.
    Vergara-de-Caso, E.
    Martorell, A.
    Romani, J.
    Lazaro, M.
    Vilarrasa, E.
    Diaz Ley, B.
    Vazquez-Osorio, I.
    Segura-Palacios, J. M.
    Azana, J. M.
    Gonzalez-Lopez, M.
    Canueto, J.
    Molina-Leyva, A.
    Leiva-Salinas, M.
    Navarro-Trivino, F. J.
    Sanchez-Paya, J.
    EXPERIMENTAL DERMATOLOGY, 2019, 28 : 43 - 44
  • [48] Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes
    Schneller-Pavelescu, Luca
    Vergarade Caso, Eduardo
    Martorell, Antonio
    Romani, Jorge
    Lazaro, Mireya
    Vilarrasa, Eva
    Diaz-Ley, Blanca
    Vazquez-Osorio, Igor
    Segura Palacios, Juan Manuel
    Manuel Azana, Jose
    Gonzalez-Lopez, Marcos A.
    Canueto, Javier
    Molina-Leyva, Alejandro
    Leiva-Salinas, Maria
    Jose Navarro-Trivino, Francisco
    Sanchez-Paya, Jose
    Pascual, Jose C.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (05) : 1455 - 1457
  • [49] Development of resistance to Mycobacterium tuberculosis is manageable in hidradenitis suppurativa. Response to 'Treatment of hidradenitis suppurativa with rifampicin: have we forgotten tuberculosis?'
    Albrecht, J.
    Mehta, S.
    Bigby, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (01) : 300 - 300
  • [50] Comment on "Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes''
    Marasca, Claudio
    Masar, Anna
    Annunziata, Maria Carmela
    Fattore, Davide
    Fabbrocini, Gabriella
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (05) : E269 - E269
12345